Block of Voltage-Gated Sodium Channels by Atomoxetine in a State- and Use-dependent Manner

Atomoxetine, a neuroactive drug, is approved for the treatment of attention-deficit/hyperactivity disorder (ADHD). It is primarily known as a high affinity blocker of the noradrenaline transporter, whereby its application leads to an increased level of the corresponding neurotransmitter in different...

Descripción completa

Detalles Bibliográficos
Autores principales: Föhr, Karl Josef, Nastos, Ariadni, Fauler, Michael, Zimmer, Thomas, Jungwirth, Bettina, Messerer, David Alexander Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959846/
https://www.ncbi.nlm.nih.gov/pubmed/33732157
http://dx.doi.org/10.3389/fphar.2021.622489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959846/
https://www.ncbi.nlm.nih.gov/pubmed/33732157
http://dx.doi.org/10.3389/fphar.2021.622489

Ejemplares similares